Ticker: CABA

Cabaletta Bio, Inc. (NASDAQ: CABA) Cabaletta Bio is a clinical-stage biotechnology company focused on developing engineered T cell therapies for autoimmune diseases. The company continues to push forward with its innovative CAR T and CAAR T therapies. Below is a summary of key developments and fi...

Cabaletta Bio, Inc. (NASDAQ: CABA) Overview Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies for autoimmune diseases. The company is advancing multiple product candidates, notably rese-cel, MuSK-CAART, and DSG3-CAART. Despite promisin...